NUVB Stock Analysis: Buy, Sell, or Hold?
NUVB - Nuvation Bio Inc.
$6.46
0.42 (6.95%)
▲
5d:
+26.17%
30d:
+36.86%
90d:
+50.93%
WAIT
LOW Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.1/10
Get Alerted When NUVB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: NUVB is 17.9% above its trading range ($5.48). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: NUVB is 17.9% above its trading range ($5.48). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: NUVB is currently trading at $6.46, which is considered extended relative to its 30-day fair value range of $4.47 to $5.48. From a valuation perspective, the stock is trading at a discount (Forward PE: -100.7) compared to its historical average (82.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NUVB is in a strong uptrend. The price is approaching resistance at $6.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: NUVB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.33 (+104.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NUVB is in a strong uptrend. The price is approaching resistance at $6.60. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: NUVB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.33 (+104.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.47 -
$5.48
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
Protect Your Profits
NUVB is technically overbought (RSI 77). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+17.9% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.0%)
- BULLISH: Trading 104.2% below Wall St target ($12.33)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to 17.9% overvaluation
Trading Range Analysis
30-Day Trading Range
$4.47 -
$5.48
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.45
Resistance Level
$6.60
Current Trend
Strong Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-100.67
Wall Street Target
$12.33
(+104.2%)
Revenue Growth (YoY)
2598.7%
Profit Margin
-102.1%
PE vs Historical
-100.7 vs 82.8
CHEAP
Share & Embed Analysis
Last updated: June 24, 2026 4:20 PM ET
Data refreshes hourly during market hours. Next update: 5:20 PM
Data refreshes hourly during market hours. Next update: 5:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUVB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Dongfang Liu
SELL
50000 shares
2026-04-17
Kerry Wentworth
SELL
36750 shares
2026-04-17
Kerry Wentworth
SELL
200000 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 66 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 60 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 69 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
Advanced NUVB Option Strategies
Professional options setups generated by AI based on today's NUVB price and gamma walls.